Lithuania Blood Disease Industry Outlook 2022 - 2026

See how Lithuania Blood Disease performed compared to key markets such as France, Germany and the United Kingdom.

Key Market Indicators

The prevalence of anemia in Lithuania is set to rise significantly over the next five years. In 2021, 4,810 hospital discharges due to this condition were recorded. This figure is expected to reach 5,490 by 2026, a rise of 2.2% each year on average. Since 2017, Lithuania has seen a 10.3% annual rise in anemia-related hospital discharges. In 2021, the country ranked 23rd in terms of prevalence globally. Denmark had more hospital discharges due to anemia, with 4,810, followed by Germany, the United Kingdom, and Poland.

Lithuania Blood Disease Market Data and Forecasts

How much will Lithuania Blood Disease Market grow to 2026?

Forecast: Prevalence of Anemia in Lithuania
Forecast: Hospital Discharges for Anaemias Cases in Lithuania
Forecast: Hospital Discharges for Anaemias Cases in Lithuania
Forecast: Hospital In Patient Discharges for Anaemias by Sex and Age in Lithuania

Other Top Countries about Blood Disease